Commentary on NICE technology appraisal guidance on ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia.

Ижил төстэй зүйлс

• Controversies in familial hypercholesterolaemia: recommendations of the NICE Guideline Development Group for the identification and management of familial hypercholesterolaemia.
  -н: Minhas, R, зэрэг
  Хэвлэсэн: (2009)
• Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
  -н: Neil, A, зэрэг
  Хэвлэсэн: (2003)
• Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
  -н: Neil, H, зэрэг
  Хэвлэсэн: (2003)
• Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia.
  -н: Neil, H, зэрэг
  Хэвлэсэн: (2004)
• Commentary: What's so special about familial hypercholesterolaemia?
  -н: Mant, D
  Хэвлэсэн: (2009)